Novartis (NVS) Wins FDA Nod for Label Expansion of Kymriah

cafead

Administrator
Staff member
  • cafead   May 31, 2022 at 10:52: AM
via Novartis NVS announced that the FDA has approved a label expansion of its CAR-T cell therapy Kymriah (tisagenlecleucel).

article source
 

<